MARC details
000 -LEADER |
fixed length control field |
02097cam a2200325 a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
EG-GiCUC |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
101228s2010 ua d f m 000 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
EG-GiCUC |
Language of cataloging |
eng |
Transcribing agency |
EG-GiCUC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
Deposite |
097 ## - Thesis Degree |
Thesis Level |
Ph.D |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
Classification number |
Cai01.19.04.Ph.D.2010.Sh.P |
100 0# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Shereef Ahmed Elsammany |
245 10 - TITLE STATEMENT |
Title |
Phase II study of low dose fixed rate infusion of gemcitabine with cisplatin and dexamethazone in resistant non- hodgkin lymphoma and correlation with MDR and BCL -2 expression / |
Statement of responsibility, etc. |
Shereef Ahmed Elsammany ; Supervised Mostafa Mahmoud Elserafy , Sameh Sayed Ahmed Shamaa , Mona Ali Sakr |
246 15 - VARYING FORM OF TITLE |
Title proper/short title |
دراسة الاستجابة للتنقيط الوريدى ذو المعدل الثابت لعقار الجمستابين مع السيزبلاتين و الديكساميثازون فى حالات الليمفوما من نوع غير الهودحكين غير المستجيبة للعلاج الكيميائى و علاقة وجود جين م.د.ر و جين ب س ل2 بالاستجابة لهذا البرنامج العلاجى |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Cairo : |
Name of publisher, distributor, etc. |
Shereef Ahmed Elsammany , |
Date of publication, distribution, etc. |
2010 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
202P. : |
Other physical details |
charts ; |
Dimensions |
25cm |
502 ## - DISSERTATION NOTE |
Dissertation note |
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Despite significant advances in the managment of patients with aggressive non - hodgkin's lymphomas (NHLs) significant proportion of patients still experience relapse following initial response to therapy or even not responding to chemotherapy from the start . So there is a great priority for the development of new chemotherapy regimens in addition to new prognostic factors for respone and survival in patients with resistant disease |
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE |
Additional physical form available note |
Issued also as CD |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Fixed rate |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Gemcitabine |
653 #4 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
N.H.L |
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mona Ali Sakr , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Mostafa Mahmoud Elserafy , |
Relator term |
|
700 0# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Sameh Sayed Ahmed Shamaa , |
Relator term |
|
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Nazla |
Reviser |
Revisor |
905 ## - LOCAL DATA ELEMENT E, LDE (RLIN) |
Cataloger |
Soheir |
Reviser |
Cataloger |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Thesis |